Alcohol consumption, metabolic syndrome and liver cancer

Shen Wei

Issue 3

Mar. 2010

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2010 > 26(3): 255-256

PDF( 1010 KB)

Alcohol consumption, metabolic syndrome and liver cancer

Shen Wei

Published Date: 2010-03-20

Abstract

FullText(HTML)

References(9)

References

[1]Donato F, GelattiU, Limina RM, et al.Southern Europe as an ex-ample of interaction between various environmental factors:a system-atic reiew of the epidemiologic evidence[J].Oncogene2006, 25 (27) ∶3756-3770.

[2]Marrero JA, Fontana RJ, Fu S, et al.Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma[J].Hepatol, 2005, 42 (2) 218-224.

[3]丁建华等.醇醛脱氢酶基因多态和饮酒习惯与肝癌易感性[J].中华肿瘤防治杂志, 2007, 14 (7) :500-504.

[4]Yoshiyuki Y, Horie Y, Kajihara M, et al.Hepatocellular carcinoma in heavy drinkers with negative markers for viral hepatitis[J].Hepa-tol.2004, 28 (4) ∶177-183.

[5]Paradis V, Zalinskis, Chelbi E, et al.Hepatocellular Carcinomas in Patients With Metabolic Syndrome Often Develop Without Significant Liver Fibrosis:A Pathological Analysis[J].Hepatology, 2009, 49 (3) ∶851-859.

[6]El-serag, HB.Rudolph KL.Hepatocellular Carcinoma:Epidemi-ology and Molecular Carcinogenesis[J].Gastrenterology, 2007, 132 (7) ∶2557-2576.

[7]季尚玮, 王江滨.2型糖尿病对原发性肝癌发病的危险性分析[J].肝脏, 2007, 12 (3) :168-170.

[8]Lemke LB, Rogers AB, Nambiar PR, et al.Obesity and non-insu-lin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma[J].Endocrinol, 2008, 199 (1) ∶21-32.

[9]Chen CL, Yang HI, Yang WS, et al.Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection:AFol-low-up Study in Taiwan[J].Gastroenterology, 2008, 135 (1) ∶111-121.

Relative Articles

[1]	Xiaofang ZHAO, Aimin ZHANG, Wengang LI, Jing SUN, Xiaoyun CHANG, Tao ZHANG, Weiping HE, Xuezhang DUAN. Efficacy and safety of stereotactic body radiation therapy in treatment of patients with unresectable cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2023, 39(11): 2657-2662. doi: 10.3969/j.issn.1001-5256.2023.11.021
[2]	Wenjun LIU, Dan DU, Baojie CHEN, Ting YAO, Xianfu LI. Application of stereotactic body radiotherapy in small hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(5): 1212-1215. doi: 10.3969/j.issn.1001-5256.2021.05.050
[3]	Wang Le, Liu LiXin, Guo XiaoHong. Value of contrast-enhanced endoscopic ultrasonography in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2246-2251. doi: 10.3969/j.issn.1001-5256.2019.10.023
[4]	Li TianTian, Sun Jing, Wang Quan, Ding JunQiang, Wang Jia, Xue Hui, Zhang Tao, Duan XueZhang. Clinical effect of stereotactic body radiotherapy in treatment of patients with small hepatocellular carcinoma and related prognostic factors[J]. Journal of Clinical Hepatology, 2018, 34(8): 1702-1706. doi: 10.3969/j.issn.1001-5256.2018.08.022
[5]	Zhang Tao, Sun Jing, He WeiPing, Li Huan, Wang Hui, Sun YingZhe, Po JunJie, Zhang JunHua, Xu HuiJun, Duan XueZhang. Clinical effect of Cyber Knife stereotactic radiosurgery in treatment of patients with small hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(4): 694-698. doi: 10.3969/j.issn.1001-5256.2017.04.019
[6]	Sun Jing, Po JunJie, Fan YuZe, He WeiPing, Li Huan, Sun YingZhe, Wang Hui, Duan XueZhang. Effect of stereotactic body radiotherapy versus intensity-modulated radiotherapy in primary liver cancer patients with secondary malignant tumor of vertebra[J]. Journal of Clinical Hepatology, 2016, 32(6): 1135-1138. doi: 10.3969/j.issn.1001-5256.2016.06.023
[7]	Ji HongBing, Chen ZhongHua. Therapeutic effect of gemcitabine hydrochloride combined with stereotactic radiotherapy for locally advanced pancre-atic cancer[J]. Journal of Clinical Hepatology, 2016, 32(3): 537-540. doi: 10.3969/j.issn.1001-5256.2016.03.030
[8]	Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the management of pancreatic cancer (2014)[J]. Journal of Clinical Hepatology, 2014, 30(12): 1240-1245. doi: 10.3969/j.issn.1001-5256.2014.12.003
[9]	Wang NanYa, Zhao HengJun, Zheng XiaoHui, Li Wei, Wang GuanJun. Clinical study of high-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(11): 1193-1195.
[10]	Ruan RunSheng, Xu KeCheng. Immunotherapy of pancreatic cancer[J]. Journal of Clinical Hepatology, 2010, 26(5): 462-467.
[11]	Wei LiRong, Liu JingYuan, Liu Zhuang. Short-term efficacy of entecavir in the treatment of chronic severe hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 56-58.
[14]	Li ChunSheng, Ni CanRong. Expression of S100A4 and E-cadherin in pancreatic carcinoma and their relationship study[J]. Journal of Clinical Hepatology, 2006, 22(3): 207-208.
[19]	Yuan ZhangJi, Yang Lei, Yao Cheng, Wang GuanJun. Observation of high intensity focused ultrasound treating 40 cases of cancer of pancreas[J]. Journal of Clinical Hepatology, 2003, 19(3): 145-146.
[20]	Guo ZhanWen, Li Yu, Yan Ying, Tian QiHe, Xu Rui. Clinical study of 3-dimensional conformal radiotherapy on primary liver cancer.[J]. Journal of Clinical Hepatology, 2002, 18(3): 164-165.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2176) PDF downloads(803)

Alcohol consumption, metabolic syndrome and liver cancer

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Alcohol consumption, metabolic syndrome and liver cancer

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content